Jan 23 (Reuters) - Suven Life Sciences Ltd SUVP.NS
* Suven Life Sciences Ltd says Suven Life Sciences secures a product patent in Australia corresponding to new chemical entities
* Suven Life Sciences Ltd says Products may be out-licensed at various phases of clinical development like at phase-I or phase-ii
* Suven Life Sciences Ltd says patent for the treatment of disorders associated with neurodegenerative diseases and the patent is valid through 2033 Source text - Further company coverage: SUVP.NS